0000950170-24-031815.txt : 20240314 0000950170-24-031815.hdr.sgml : 20240314 20240314203506 ACCESSION NUMBER: 0000950170-24-031815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240309 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cigler Tessa CENTRAL INDEX KEY: 0002015142 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 24752176 MAIL ADDRESS: STREET 1: C/O ATOSSA THERAPEUTICS, INC. STREET 2: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 ownership.xml 4 X0508 4 2024-03-09 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0002015142 Cigler Tessa C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104 true false false false false Stock Option (right to buy) 1.09 2024-03-09 4 A false 20834 0.00 A 2034-03-09 Common Stock 20834 20834 D The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date. /s/ Heather Rees, as attorney-in-fact for Tessa Cigler 2024-03-14